Hepatitis B Blood Test: Reading HBsAg & Antibodies
The hepatitis B blood test is a panel — HBsAg, anti-HBs, and anti-HBc. Learn what each marker means, how to read the combinations, and what your result says about immunity or infection.
The hepatitis B blood test isn't a single "normal or abnormal" number — it's a panel of several markers (antigens and antibodies) whose combination is what matters. Depending on which markers are present, your result shows whether you are susceptible (unprotected), immune (from the vaccine or a resolved infection), or living with a current infection (recent or chronic). This guide explains each marker, gives you a plain-language interpretation table, and covers screening and vaccination. The hepatitis B panel is one of the infection & serology tests; it's often read alongside hepatitis C, HIV, and liver function tests.
Key takeaways
- The hepatitis B panel uses several markers: the surface antigen (HBsAg), the anti-HBs antibody, the anti-HBc antibody (total and IgM), and — for follow-up — HBeAg/anti-HBe and the viral load (HBV DNA).12
- HBsAg positive = current infection — acute, or chronic if the antigen persists for more than 6 months.31
- Anti-HBs positive = protection — from vaccination (anti-HBs alone) or from a resolved infection (anti-HBs + anti-HBc). A level ≥ 10 mIU/mL is considered protective.14
- Anti-HBc = contact with the virus (past or present); IgM anti-HBc points to a recent/acute infection. An isolated anti-HBc is a result your clinician needs to interpret.15
- Hepatitis B is vaccine-preventable (highly effective), and the CDC now recommends that all adults be screened at least once in their lifetime.16
- A positive HBsAg is not a life sentence: chronic hepatitis B is monitored, treated when needed, and most people live normal lives under medical follow-up.25
What is the hepatitis B blood test?
Hepatitis B is a liver infection caused by the hepatitis B virus (HBV), which spreads through blood, sexual contact, and from mother to child at birth. A single blood draw can sort out where you stand, but it measures several different things, because the virus leaves multiple traces in the blood: antigens (pieces of the virus itself) and antibodies (your immune system's response).37
Reading the panel means knowing what each marker "says":
- HBsAg (surface antigen) — the outer coat of the virus. If it's in your blood, the virus is present: you have a current infection (recent, or chronic if HBsAg persists beyond 6 months).1
- Anti-HBs (surface antibody) — the antibody against that coat. It neutralizes the virus, so its presence means immunity, from the vaccine or from a resolved infection.14
- Anti-HBc (core antibody, total) — directed against the core of the virus. It appears at first contact and persists for life, so it marks exposure to HBV (past or present). Crucially, the vaccine does not produce it — this is how a vaccine immunity is told apart from a post-infection immunity.15
- IgM anti-HBc — a subtype that shows up early in infection: its presence points to a recent/acute infection.1
- HBeAg / anti-HBe and HBV DNA (viral load) — these measure replication and infectiousness. They're mainly used to monitor chronic hepatitis B with a specialist.2
Why the test is done
Your clinician may order a hepatitis B panel for several reasons:18
- screening — the CDC now recommends testing every adult at least once, and the USPSTF recommends screening people at increased risk (those born in high-prevalence regions, people who inject drugs, people with HIV, household or sexual contacts of an infected person, and others);18
- routinely in pregnancy: HBsAg testing is standard for every pregnant person, because finding it lets the newborn be protected at birth;19
- before certain treatments (immunosuppressants, chemotherapy) that can reactivate a dormant virus;
- to check immunity after vaccination (an anti-HBs level) in people at risk;
- to work up unexplained liver abnormalities, alongside liver function tests.
The logic behind universal adult screening is simple: many people carrying the virus don't know it. A quick test opens the door to vaccinating susceptible people and linking infected people to care — a strategy widely viewed as cost-effective on the path to eliminating HBV.65
How the test is done
The hepatitis B panel is a standard blood draw from a vein, and you do not need to fast for it — antigens and antibodies don't change with a meal, so you can eat and drink normally beforehand. Fasting is only required if your clinician has combined it on the same order with a test that needs it (for example a fasting blood glucose test). Follow the instructions on your order.3
Understanding your results
There are no numeric "normal ranges" here the way there are for cholesterol: each marker is reported negative or positive (HBV DNA is the exception — it's quantified in IU/mL). What matters is the combination. Here is what each marker means, then an interpretation table for the main profiles.
| Marker | What a positive result means |
|---|---|
| HBsAg (surface antigen) | Current infection (acute, or chronic if > 6 months) |
| Anti-HBs | Immunity / protection (vaccine or resolved infection) — protective ≈ 10 mIU/mL |
| Anti-HBc, total | Contact with the virus (past or present); never from vaccination alone |
| IgM anti-HBc | Recent / acute infection |
| HBeAg / anti-HBe | Markers of replication and infectiousness (follow-up) |
| HBV DNA (viral load) | Amount of virus in the blood (follow-up, treatment decisions) |
Reading the profiles — interpretation rests mainly on the trio HBsAg / anti-HBc / anti-HBs:1
| HBsAg | Anti-HBc | Anti-HBs | Interpretation |
|---|---|---|---|
| negative | negative | negative | Susceptible: never exposed, not immune → vaccination recommended |
| negative | negative | positive | Immune due to vaccination |
| negative | positive | positive | Immune due to a resolved infection |
| positive | positive (IgM +) | negative | Acute (recent) infection |
| positive | positive (IgM −) | negative | Chronic infection (HBsAg > 6 months) |
| negative | positive | negative | Isolated anti-HBc: needs interpretation (see below) |
These results vary by lab and assay; only your clinician interprets the full picture in your context.
HBsAg positive: a current infection
A positive HBsAg means the virus is present in your blood. Two situations:
- if the antigen appeared recently (often with IgM anti-HBc), this is acute hepatitis B. In adults it clears on its own in the great majority of cases: HBsAg disappears and anti-HBs appears (recovery with immunity);5
- if HBsAg persists beyond 6 months, it's chronic hepatitis B. The virus stays present, but that does not mean the liver is necessarily damaged: many people are inactive carriers and feel well. Whether to simply monitor or start antiviral treatment is decided by the clinician, based on viral load, liver enzymes, and the state of the liver.2
Let's defuse a myth: "HBsAg positive" is not a life sentence. Chronic hepatitis B today is a monitored condition and, when needed, a treatable one — effective antiviral drugs keep the virus under long-term control. With regular follow-up, most people affected lead a normal life. Stigma sadly still discourages testing and care, which is exactly why it helps to talk about it calmly with a professional.52
Anti-HBs positive: you're protected
An anti-HBs positive result (with HBsAg negative) is good news: you are immune. If it's alone (anti-HBc negative), the immunity came from the vaccine. If it comes with anti-HBc positive, it came from a past, resolved infection. Either way, you are not contagious and you're protected. A level ≥ 10 mIU/mL is generally considered protective.14
Everything negative: you're susceptible
If everything is negative (HBsAg, anti-HBs, and anti-HBc), you've never met the virus and you're not immune: you're susceptible. This is exactly the situation where vaccination protects you — worth discussing with your clinician.46
Isolated anti-HBc: a result to interpret
A positive anti-HBc alone (HBsAg and anti-HBs negative) is an ambiguous profile that your clinician needs to interpret. It can reflect a resolved past infection whose anti-HBs faded over time (the most common explanation), a false positive, the tail end of a recent infection, or, less often, an "occult" low-level infection. Testing HBV DNA and repeating the panel are often needed.15
What affects your results
Several things shape how a hepatitis B panel reads: the time since exposure (markers don't all appear together, and there's a window period at the very start), your vaccination status, your age at infection (progression to chronic infection is far more common in newborns and young children than in adults), immunosuppression (HIV, immunosuppressive drugs), and possible co-infection with hepatitis D (delta), which affects only people who are HBsAg positive and should be tested for at least once.910 Always mention your vaccinations, your medications, and the context of the draw — they change the interpretation.
Recent research
According to recent PubMed-indexed publications:
- Toward universal adult screening. U.S. health authorities now recommend that every adult be tested at least once for hepatitis B (HBsAg, anti-HBs, anti-HBc) to find undiagnosed carriers, vaccinate susceptible people, and link infected people to care — a strategy judged cost-effective on the path to HBV elimination.65 (So S et al., JAMA, 2023 — DOI.)
- Preventing mother-to-child transmission. Combining vaccination + immune globulin at birth with antiviral treatment of highly viremic mothers in late pregnancy sharply cuts the risk of passing HBV to the newborn.9 A recent randomized trial (JAMA, 2025; NCT03476083) shows that starting tenofovir as early as week 16 of pregnancy is as effective as the standard schedule — a useful option where immune globulin isn't available.11 (Pan CQ et al., JAMA, 2025 — DOI.)
- A chronic disease managed better than ever. Recent practice reviews stress that chronic hepatitis B is not always treated right away: the choice between monitoring and antivirals rests on viral load, liver enzymes, and liver status, with tailored liver-cancer surveillance for people at risk.2
- Don't forget hepatitis D. In people who are HBsAg positive, one-time testing for hepatitis D (delta) is now recommended and judged cost-effective, because this co-infection worsens the liver outlook.10
These findings concern diagnosis and research; they do not authorize self-medication and do not replace your physician's advice.
Get your hepatitis B panel interpreted by AI DiagMe
A hepatitis B panel is never read marker by marker: its meaning depends on the combination of HBsAg, anti-HBs, and anti-HBc, your vaccination status, your other infection & serology tests, and your liver function tests. That cross-reading is what gives the result its real value.
👉 AI DiagMe interprets your lab results — blood, urine, or stool — in plain language, taking your whole profile into account. An informational service that does not provide a diagnosis and complements, never replaces, your physician.
Frequently asked questions
What is a hepatitis B blood test?
What does a positive HBsAg mean?
What does a positive anti-HBs mean?
What's the difference between anti-HBs and anti-HBc?
Am I protected if I've been vaccinated?
Is hepatitis B serious? Can it be cured?
Do I need to fast for a hepatitis B blood test?
Does a positive hepatitis B test mean I have liver cancer?
Can I pass hepatitis B to my baby?
The bottom line
The hepatitis B blood test is not a single number but a panel: it's the combination of HBsAg (virus present), anti-HBs (protection), and anti-HBc (past or present contact), rounded out when needed by IgM anti-HBc, HBeAg/anti-HBe, and HBV DNA, that shows whether you're susceptible, immune, or infected. Remember that a positive HBsAg flags a current infection (chronic beyond 6 months) but is not a life sentence — the disease is monitored and treatable — and that vaccination effectively protects susceptible people. No marker is read alone: it's your whole profile that counts, which is what AI DiagMe provides, alongside your physician.
Sources
Official U.S. sources and peer-reviewed publications (PubMed) used for this guide:
Footnotes
-
Centers for Disease Control and Prevention (CDC) — Hepatitis B: Interpretation of Serologic Test Results & Screening Recommendations. cdc.gov ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8 ↩9 ↩10 ↩11 ↩12 ↩13 ↩14 ↩15
-
Pan CQ, Saadi S, Ghany MG, et al. Technical systematic review supporting the 2025 AASLD Practice Guideline on management of chronic hepatitis B. Hepatology, 2025. PubMed · DOI ↩ ↩2 ↩3 ↩4 ↩5 ↩6
-
MedlinePlus (U.S. National Library of Medicine, NIH) — Hepatitis B Test. medlineplus.gov ↩ ↩2 ↩3
-
Cleveland Clinic — Hepatitis B Panel and Test Results. my.clevelandclinic.org ↩ ↩2 ↩3 ↩4
-
Roma K, Chandler TM, Dossaji Z, et al. A Review of the Systemic Manifestations of Hepatitis B Virus Infection, Hepatitis D Virus, Hepatocellular Carcinoma, and Emerging Therapies. Gastro Hep Adv, 2023. PubMed · DOI ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8
-
So S, Terrault N, Conners EE. Universal Adult Hepatitis B Screening and Vaccination as the Path to Elimination. JAMA, 2023. PubMed · DOI ↩ ↩2 ↩3 ↩4
-
Mayo Clinic — Hepatitis B: Symptoms, causes and diagnosis. mayoclinic.org ↩
-
U.S. Preventive Services Task Force (USPSTF) — Hepatitis B Virus Infection in Adolescents and Adults: Screening. uspreventiveservicestaskforce.org ↩ ↩2
-
Veronese P, Dodi I, Esposito S, Indolfi G. Prevention of vertical transmission of hepatitis B virus infection. World J Gastroenterol, 2021. PubMed · DOI ↩ ↩2 ↩3
-
Toy M, Hutton D, Teshale E, et al. Cost-Effectiveness of One-time Universal Testing for Hepatitis D Among Adults With Chronic Hepatitis B in the United States. Clin Infect Dis, 2025. PubMed · DOI ↩ ↩2
-
Pan CQ, Dai E, Mo Z, et al. Tenofovir and Hepatitis B Virus Transmission During Pregnancy: A Randomized Clinical Trial (NCT03476083). JAMA, 2025. PubMed · DOI ↩